Clinical Trial Update: Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction therapy with idarubicin and etoposide followed by sequential or concurrent azacitidine and maintenance azacitidine in acute m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Etoposide (Etoposide)
• Idarubicin (idarubicin)

Snippet

Sponsor: University of Ulm | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: COMPLETED